Menu
Live News EQUITY M impact

JAGX Submits FDA Application

Jaguar Health completes submission of new animal drug application for full FDA approval of Crofelemer for treatment of chemotherapy-induced diarrhea in dogs

JAGX

JAGX - Jaguar Health Completes Submission of New Animal Drug Application for Full FDA Approval of Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs